Exchange: OTC·Updated 08:05 AM EDT

SBMJF Dimerix Limited

$0.35
$0.1314
(37.54%)
Pre-Market
Prev Close $0.35
Mkt Cap$210.14M
Vol28,879.00

About SBMJF

Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. It focuses on the development of Dimerix DMX-200 drug candidate in both renal and respiratory indications and the development of Dimerix DMX-700 pre-clinical asset in Chronic Obstructive Pulmonary Disease. The company was founded on May 13, 1975 and is headquartered in Melbourne, Australia.
50

Sentiment

How do you feel about SBMJF?

Advertisement|Remove ads.